Global Hematologic Malignancies Detection Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hematologic Malignancies Detection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
By Company
- ArcherDx
- Bio-Rad Laboratories
- sysmex
- Invitae
- NeoGenomics Laboratories
- Abbott Laboratories
- Cancer Genetics
- Adaptive Biotechnologies Corporation
- Asuragen
- Invivoscribe
- Nanjing Shihejiyin Technology
- Annaroad Gene Technology
- BGI Genomics
- Polymerase Chain Reaction
- Immunochemistry
- Next Generation Sequencing
- Fluorescence in Situ Hybridization
- Others
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Myeloproliferative Neoplasms
- Lymphoma
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction
1.2.3 Immunochemistry
1.2.4 Next Generation Sequencing
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Multiple Myeloma
1.3.3 Myelodysplastic Syndrome
1.3.4 Leukemia
1.3.5 Myeloproliferative Neoplasms
1.3.6 Lymphoma
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Hematologic Malignancies Detection Market Perspective (2018-2029)
2.2 Hematologic Malignancies Detection Growth Trends by Region
2.2.1 Global Hematologic Malignancies Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hematologic Malignancies Detection Historic Market Size by Region (2018-2023)
2.2.3 Hematologic Malignancies Detection Forecasted Market Size by Region (2024-2029)
2.3 Hematologic Malignancies Detection Market Dynamics
2.3.1 Hematologic Malignancies Detection Industry Trends
2.3.2 Hematologic Malignancies Detection Market Drivers
2.3.3 Hematologic Malignancies Detection Market Challenges
2.3.4 Hematologic Malignancies Detection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hematologic Malignancies Detection Players by Revenue
3.1.1 Global Top Hematologic Malignancies Detection Players by Revenue (2018-2023)
3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Players (2018-2023)
3.2 Global Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematologic Malignancies Detection Revenue
3.4 Global Hematologic Malignancies Detection Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Detection Revenue in 2022
3.5 Hematologic Malignancies Detection Key Players Head office and Area Served
3.6 Key Players Hematologic Malignancies Detection Product Solution and Service
3.7 Date of Enter into Hematologic Malignancies Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HEMATOLOGIC MALIGNANCIES DETECTION BREAKDOWN DATA BY TYPE
4.1 Global Hematologic Malignancies Detection Historic Market Size by Type (2018-2023)
4.2 Global Hematologic Malignancies Detection Forecasted Market Size by Type (2024-2029)
5 HEMATOLOGIC MALIGNANCIES DETECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Hematologic Malignancies Detection Historic Market Size by Application (2018-2023)
5.2 Global Hematologic Malignancies Detection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hematologic Malignancies Detection Market Size (2018-2029)
6.2 North America Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hematologic Malignancies Detection Market Size by Country (2018-2023)
6.4 North America Hematologic Malignancies Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Hematologic Malignancies Detection Market Size (2018-2029)
7.2 Europe Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hematologic Malignancies Detection Market Size by Country (2018-2023)
7.4 Europe Hematologic Malignancies Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Hematologic Malignancies Detection Market Size (2018-2029)
8.2 Asia-Pacific Hematologic Malignancies Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Hematologic Malignancies Detection Market Size (2018-2029)
9.2 Latin America Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hematologic Malignancies Detection Market Size by Country (2018-2023)
9.4 Latin America Hematologic Malignancies Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hematologic Malignancies Detection Market Size (2018-2029)
10.2 Middle East & Africa Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 ArcherDx
11.1.1 ArcherDx Company Detail
11.1.2 ArcherDx Business Overview
11.1.3 ArcherDx Hematologic Malignancies Detection Introduction
11.1.4 ArcherDx Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.1.5 ArcherDx Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 sysmex
11.3.1 sysmex Company Detail
11.3.2 sysmex Business Overview
11.3.3 sysmex Hematologic Malignancies Detection Introduction
11.3.4 sysmex Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.3.5 sysmex Recent Development
11.4 Invitae
11.4.1 Invitae Company Detail
11.4.2 Invitae Business Overview
11.4.3 Invitae Hematologic Malignancies Detection Introduction
11.4.4 Invitae Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.4.5 Invitae Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Detail
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Hematologic Malignancies Detection Introduction
11.6.4 Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Detail
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Hematologic Malignancies Detection Introduction
11.7.4 Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.7.5 Cancer Genetics Recent Development
11.8 Adaptive Biotechnologies Corporation
11.8.1 Adaptive Biotechnologies Corporation Company Detail
11.8.2 Adaptive Biotechnologies Corporation Business Overview
11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Introduction
11.8.4 Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.8.5 Adaptive Biotechnologies Corporation Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Detail
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hematologic Malignancies Detection Introduction
11.9.4 Asuragen Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.9.5 Asuragen Recent Development
11.10 Invivoscribe
11.10.1 Invivoscribe Company Detail
11.10.2 Invivoscribe Business Overview
11.10.3 Invivoscribe Hematologic Malignancies Detection Introduction
11.10.4 Invivoscribe Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.10.5 Invivoscribe Recent Development
11.11 Nanjing Shihejiyin Technology
11.11.1 Nanjing Shihejiyin Technology Company Detail
11.11.2 Nanjing Shihejiyin Technology Business Overview
11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Introduction
11.11.4 Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.11.5 Nanjing Shihejiyin Technology Recent Development
11.12 Annaroad Gene Technology
11.12.1 Annaroad Gene Technology Company Detail
11.12.2 Annaroad Gene Technology Business Overview
11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Introduction
11.12.4 Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.12.5 Annaroad Gene Technology Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Hematologic Malignancies Detection Introduction
11.13.4 BGI Genomics Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.13.5 BGI Genomics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematologic Malignancies Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Polymerase Chain Reaction
1.2.3 Immunochemistry
1.2.4 Next Generation Sequencing
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hematologic Malignancies Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Multiple Myeloma
1.3.3 Myelodysplastic Syndrome
1.3.4 Leukemia
1.3.5 Myeloproliferative Neoplasms
1.3.6 Lymphoma
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Hematologic Malignancies Detection Market Perspective (2018-2029)
2.2 Hematologic Malignancies Detection Growth Trends by Region
2.2.1 Global Hematologic Malignancies Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hematologic Malignancies Detection Historic Market Size by Region (2018-2023)
2.2.3 Hematologic Malignancies Detection Forecasted Market Size by Region (2024-2029)
2.3 Hematologic Malignancies Detection Market Dynamics
2.3.1 Hematologic Malignancies Detection Industry Trends
2.3.2 Hematologic Malignancies Detection Market Drivers
2.3.3 Hematologic Malignancies Detection Market Challenges
2.3.4 Hematologic Malignancies Detection Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Hematologic Malignancies Detection Players by Revenue
3.1.1 Global Top Hematologic Malignancies Detection Players by Revenue (2018-2023)
3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Players (2018-2023)
3.2 Global Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematologic Malignancies Detection Revenue
3.4 Global Hematologic Malignancies Detection Market Concentration Ratio
3.4.1 Global Hematologic Malignancies Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Detection Revenue in 2022
3.5 Hematologic Malignancies Detection Key Players Head office and Area Served
3.6 Key Players Hematologic Malignancies Detection Product Solution and Service
3.7 Date of Enter into Hematologic Malignancies Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HEMATOLOGIC MALIGNANCIES DETECTION BREAKDOWN DATA BY TYPE
4.1 Global Hematologic Malignancies Detection Historic Market Size by Type (2018-2023)
4.2 Global Hematologic Malignancies Detection Forecasted Market Size by Type (2024-2029)
5 HEMATOLOGIC MALIGNANCIES DETECTION BREAKDOWN DATA BY APPLICATION
5.1 Global Hematologic Malignancies Detection Historic Market Size by Application (2018-2023)
5.2 Global Hematologic Malignancies Detection Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Hematologic Malignancies Detection Market Size (2018-2029)
6.2 North America Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hematologic Malignancies Detection Market Size by Country (2018-2023)
6.4 North America Hematologic Malignancies Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Hematologic Malignancies Detection Market Size (2018-2029)
7.2 Europe Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hematologic Malignancies Detection Market Size by Country (2018-2023)
7.4 Europe Hematologic Malignancies Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Hematologic Malignancies Detection Market Size (2018-2029)
8.2 Asia-Pacific Hematologic Malignancies Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Hematologic Malignancies Detection Market Size (2018-2029)
9.2 Latin America Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hematologic Malignancies Detection Market Size by Country (2018-2023)
9.4 Latin America Hematologic Malignancies Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hematologic Malignancies Detection Market Size (2018-2029)
10.2 Middle East & Africa Hematologic Malignancies Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 ArcherDx
11.1.1 ArcherDx Company Detail
11.1.2 ArcherDx Business Overview
11.1.3 ArcherDx Hematologic Malignancies Detection Introduction
11.1.4 ArcherDx Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.1.5 ArcherDx Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Introduction
11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 sysmex
11.3.1 sysmex Company Detail
11.3.2 sysmex Business Overview
11.3.3 sysmex Hematologic Malignancies Detection Introduction
11.3.4 sysmex Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.3.5 sysmex Recent Development
11.4 Invitae
11.4.1 Invitae Company Detail
11.4.2 Invitae Business Overview
11.4.3 Invitae Hematologic Malignancies Detection Introduction
11.4.4 Invitae Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.4.5 Invitae Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Detail
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Introduction
11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Hematologic Malignancies Detection Introduction
11.6.4 Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Detail
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Hematologic Malignancies Detection Introduction
11.7.4 Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.7.5 Cancer Genetics Recent Development
11.8 Adaptive Biotechnologies Corporation
11.8.1 Adaptive Biotechnologies Corporation Company Detail
11.8.2 Adaptive Biotechnologies Corporation Business Overview
11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Introduction
11.8.4 Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.8.5 Adaptive Biotechnologies Corporation Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Detail
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hematologic Malignancies Detection Introduction
11.9.4 Asuragen Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.9.5 Asuragen Recent Development
11.10 Invivoscribe
11.10.1 Invivoscribe Company Detail
11.10.2 Invivoscribe Business Overview
11.10.3 Invivoscribe Hematologic Malignancies Detection Introduction
11.10.4 Invivoscribe Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.10.5 Invivoscribe Recent Development
11.11 Nanjing Shihejiyin Technology
11.11.1 Nanjing Shihejiyin Technology Company Detail
11.11.2 Nanjing Shihejiyin Technology Business Overview
11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Introduction
11.11.4 Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.11.5 Nanjing Shihejiyin Technology Recent Development
11.12 Annaroad Gene Technology
11.12.1 Annaroad Gene Technology Company Detail
11.12.2 Annaroad Gene Technology Business Overview
11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Introduction
11.12.4 Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.12.5 Annaroad Gene Technology Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Hematologic Malignancies Detection Introduction
11.13.4 BGI Genomics Revenue in Hematologic Malignancies Detection Business (2018-2023)
11.13.5 BGI Genomics Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Hematologic Malignancies Detection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Immunochemistry
Table 4. Key Players of Next Generation Sequencing
Table 5. Key Players of Fluorescence in Situ Hybridization
Table 6. Key Players of Others
Table 7. Global Hematologic Malignancies Detection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hematologic Malignancies Detection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Hematologic Malignancies Detection Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Hematologic Malignancies Detection Market Share by Region (2018-2023)
Table 11. Global Hematologic Malignancies Detection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Hematologic Malignancies Detection Market Share by Region (2024-2029)
Table 13. Hematologic Malignancies Detection Market Trends
Table 14. Hematologic Malignancies Detection Market Drivers
Table 15. Hematologic Malignancies Detection Market Challenges
Table 16. Hematologic Malignancies Detection Market Restraints
Table 17. Global Hematologic Malignancies Detection Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Hematologic Malignancies Detection Market Share by Players (2018-2023)
Table 19. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Table 20. Ranking of Global Top Hematologic Malignancies Detection Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Hematologic Malignancies Detection Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hematologic Malignancies Detection Product Solution and Service
Table 24. Date of Enter into Hematologic Malignancies Detection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematologic Malignancies Detection Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Hematologic Malignancies Detection Revenue Market Share by Type (2018-2023)
Table 28. Global Hematologic Malignancies Detection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Hematologic Malignancies Detection Revenue Market Share by Type (2024-2029)
Table 30. Global Hematologic Malignancies Detection Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Hematologic Malignancies Detection Revenue Market Share by Application (2018-2023)
Table 32. Global Hematologic Malignancies Detection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Hematologic Malignancies Detection Revenue Market Share by Application (2024-2029)
Table 34. North America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Hematologic Malignancies Detection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 49. ArcherDx Company Detail
Table 50. ArcherDx Business Overview
Table 51. ArcherDx Hematologic Malignancies Detection Product
Table 52. ArcherDx Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 53. ArcherDx Recent Development
Table 54. Bio-Rad Laboratories Company Detail
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Hematologic Malignancies Detection Product
Table 57. Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 58. Bio-Rad Laboratories Recent Development
Table 59. sysmex Company Detail
Table 60. sysmex Business Overview
Table 61. sysmex Hematologic Malignancies Detection Product
Table 62. sysmex Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 63. sysmex Recent Development
Table 64. Invitae Company Detail
Table 65. Invitae Business Overview
Table 66. Invitae Hematologic Malignancies Detection Product
Table 67. Invitae Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 68. Invitae Recent Development
Table 69. NeoGenomics Laboratories Company Detail
Table 70. NeoGenomics Laboratories Business Overview
Table 71. NeoGenomics Laboratories Hematologic Malignancies Detection Product
Table 72. NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 73. NeoGenomics Laboratories Recent Development
Table 74. Abbott Laboratories Company Detail
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Hematologic Malignancies Detection Product
Table 77. Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Cancer Genetics Company Detail
Table 80. Cancer Genetics Business Overview
Table 81. Cancer Genetics Hematologic Malignancies Detection Product
Table 82. Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 83. Cancer Genetics Recent Development
Table 84. Adaptive Biotechnologies Corporation Company Detail
Table 85. Adaptive Biotechnologies Corporation Business Overview
Table 86. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product
Table 87. Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 88. Adaptive Biotechnologies Corporation Recent Development
Table 89. Asuragen Company Detail
Table 90. Asuragen Business Overview
Table 91. Asuragen Hematologic Malignancies Detection Product
Table 92. Asuragen Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 93. Asuragen Recent Development
Table 94. Invivoscribe Company Detail
Table 95. Invivoscribe Business Overview
Table 96. Invivoscribe Hematologic Malignancies Detection Product
Table 97. Invivoscribe Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 98. Invivoscribe Recent Development
Table 99. Nanjing Shihejiyin Technology Company Detail
Table 100. Nanjing Shihejiyin Technology Business Overview
Table 101. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product
Table 102. Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 103. Nanjing Shihejiyin Technology Recent Development
Table 104. Annaroad Gene Technology Company Detail
Table 105. Annaroad Gene Technology Business Overview
Table 106. Annaroad Gene Technology Hematologic Malignancies Detection Product
Table 107. Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 108. Annaroad Gene Technology Recent Development
Table 109. BGI Genomics Company Detail
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Hematologic Malignancies Detection Product
Table 112. BGI Genomics Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
Table 1. Global Hematologic Malignancies Detection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of Immunochemistry
Table 4. Key Players of Next Generation Sequencing
Table 5. Key Players of Fluorescence in Situ Hybridization
Table 6. Key Players of Others
Table 7. Global Hematologic Malignancies Detection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Hematologic Malignancies Detection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Hematologic Malignancies Detection Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Hematologic Malignancies Detection Market Share by Region (2018-2023)
Table 11. Global Hematologic Malignancies Detection Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Hematologic Malignancies Detection Market Share by Region (2024-2029)
Table 13. Hematologic Malignancies Detection Market Trends
Table 14. Hematologic Malignancies Detection Market Drivers
Table 15. Hematologic Malignancies Detection Market Challenges
Table 16. Hematologic Malignancies Detection Market Restraints
Table 17. Global Hematologic Malignancies Detection Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Hematologic Malignancies Detection Market Share by Players (2018-2023)
Table 19. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Table 20. Ranking of Global Top Hematologic Malignancies Detection Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Hematologic Malignancies Detection Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hematologic Malignancies Detection Product Solution and Service
Table 24. Date of Enter into Hematologic Malignancies Detection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematologic Malignancies Detection Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Hematologic Malignancies Detection Revenue Market Share by Type (2018-2023)
Table 28. Global Hematologic Malignancies Detection Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Hematologic Malignancies Detection Revenue Market Share by Type (2024-2029)
Table 30. Global Hematologic Malignancies Detection Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Hematologic Malignancies Detection Revenue Market Share by Application (2018-2023)
Table 32. Global Hematologic Malignancies Detection Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Hematologic Malignancies Detection Revenue Market Share by Application (2024-2029)
Table 34. North America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Hematologic Malignancies Detection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2024-2029) & (US$ Million)
Table 49. ArcherDx Company Detail
Table 50. ArcherDx Business Overview
Table 51. ArcherDx Hematologic Malignancies Detection Product
Table 52. ArcherDx Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 53. ArcherDx Recent Development
Table 54. Bio-Rad Laboratories Company Detail
Table 55. Bio-Rad Laboratories Business Overview
Table 56. Bio-Rad Laboratories Hematologic Malignancies Detection Product
Table 57. Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 58. Bio-Rad Laboratories Recent Development
Table 59. sysmex Company Detail
Table 60. sysmex Business Overview
Table 61. sysmex Hematologic Malignancies Detection Product
Table 62. sysmex Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 63. sysmex Recent Development
Table 64. Invitae Company Detail
Table 65. Invitae Business Overview
Table 66. Invitae Hematologic Malignancies Detection Product
Table 67. Invitae Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 68. Invitae Recent Development
Table 69. NeoGenomics Laboratories Company Detail
Table 70. NeoGenomics Laboratories Business Overview
Table 71. NeoGenomics Laboratories Hematologic Malignancies Detection Product
Table 72. NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 73. NeoGenomics Laboratories Recent Development
Table 74. Abbott Laboratories Company Detail
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Hematologic Malignancies Detection Product
Table 77. Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Cancer Genetics Company Detail
Table 80. Cancer Genetics Business Overview
Table 81. Cancer Genetics Hematologic Malignancies Detection Product
Table 82. Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 83. Cancer Genetics Recent Development
Table 84. Adaptive Biotechnologies Corporation Company Detail
Table 85. Adaptive Biotechnologies Corporation Business Overview
Table 86. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product
Table 87. Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 88. Adaptive Biotechnologies Corporation Recent Development
Table 89. Asuragen Company Detail
Table 90. Asuragen Business Overview
Table 91. Asuragen Hematologic Malignancies Detection Product
Table 92. Asuragen Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 93. Asuragen Recent Development
Table 94. Invivoscribe Company Detail
Table 95. Invivoscribe Business Overview
Table 96. Invivoscribe Hematologic Malignancies Detection Product
Table 97. Invivoscribe Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 98. Invivoscribe Recent Development
Table 99. Nanjing Shihejiyin Technology Company Detail
Table 100. Nanjing Shihejiyin Technology Business Overview
Table 101. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product
Table 102. Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 103. Nanjing Shihejiyin Technology Recent Development
Table 104. Annaroad Gene Technology Company Detail
Table 105. Annaroad Gene Technology Business Overview
Table 106. Annaroad Gene Technology Hematologic Malignancies Detection Product
Table 107. Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 108. Annaroad Gene Technology Recent Development
Table 109. BGI Genomics Company Detail
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Hematologic Malignancies Detection Product
Table 112. BGI Genomics Revenue in Hematologic Malignancies Detection Business (2018-2023) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Hematologic Malignancies Detection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Hematologic Malignancies Detection Market Share by Type: 2022 VS 2029
Figure 3. Polymerase Chain Reaction Features
Figure 4. Immunochemistry Features
Figure 5. Next Generation Sequencing Features
Figure 6. Fluorescence in Situ Hybridization Features
Figure 7. Others Features
Figure 8. Global Hematologic Malignancies Detection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Hematologic Malignancies Detection Market Share by Application: 2022 VS 2029
Figure 10. Multiple Myeloma Case Studies
Figure 11. Myelodysplastic Syndrome Case Studies
Figure 12. Leukemia Case Studies
Figure 13. Myeloproliferative Neoplasms Case Studies
Figure 14. Lymphoma Case Studies
Figure 15. Others Case Studies
Figure 16. Hematologic Malignancies Detection Report Years Considered
Figure 17. Global Hematologic Malignancies Detection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Hematologic Malignancies Detection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Hematologic Malignancies Detection Market Share by Region: 2022 VS 2029
Figure 20. Global Hematologic Malignancies Detection Market Share by Players in 2022
Figure 21. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Hematologic Malignancies Detection Revenue in 2022
Figure 23. North America Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 25. United States Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 29. Germany Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Hematologic Malignancies Detection Market Share by Region (2018-2029)
Figure 37. China Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 45. Mexico Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 49. Turkey Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. ArcherDx Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 53. sysmex Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 54. Invitae Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 55. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 56. Abbott Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 57. Cancer Genetics Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 58. Adaptive Biotechnologies Corporation Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 59. Asuragen Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 60. Invivoscribe Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 61. Nanjing Shihejiyin Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 62. Annaroad Gene Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 63. BGI Genomics Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Figure 1. Global Hematologic Malignancies Detection Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Hematologic Malignancies Detection Market Share by Type: 2022 VS 2029
Figure 3. Polymerase Chain Reaction Features
Figure 4. Immunochemistry Features
Figure 5. Next Generation Sequencing Features
Figure 6. Fluorescence in Situ Hybridization Features
Figure 7. Others Features
Figure 8. Global Hematologic Malignancies Detection Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Hematologic Malignancies Detection Market Share by Application: 2022 VS 2029
Figure 10. Multiple Myeloma Case Studies
Figure 11. Myelodysplastic Syndrome Case Studies
Figure 12. Leukemia Case Studies
Figure 13. Myeloproliferative Neoplasms Case Studies
Figure 14. Lymphoma Case Studies
Figure 15. Others Case Studies
Figure 16. Hematologic Malignancies Detection Report Years Considered
Figure 17. Global Hematologic Malignancies Detection Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 18. Global Hematologic Malignancies Detection Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Hematologic Malignancies Detection Market Share by Region: 2022 VS 2029
Figure 20. Global Hematologic Malignancies Detection Market Share by Players in 2022
Figure 21. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Figure 22. The Top 10 and 5 Players Market Share by Hematologic Malignancies Detection Revenue in 2022
Figure 23. North America Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 25. United States Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 29. Germany Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Hematologic Malignancies Detection Market Share by Region (2018-2029)
Figure 37. China Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 45. Mexico Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Hematologic Malignancies Detection Market Share by Country (2018-2029)
Figure 49. Turkey Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Hematologic Malignancies Detection Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. ArcherDx Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 53. sysmex Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 54. Invitae Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 55. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 56. Abbott Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 57. Cancer Genetics Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 58. Adaptive Biotechnologies Corporation Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 59. Asuragen Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 60. Invivoscribe Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 61. Nanjing Shihejiyin Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 62. Annaroad Gene Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 63. BGI Genomics Revenue Growth Rate in Hematologic Malignancies Detection Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
